For your information...
The MDS Beacon: Researchers Develop New MDS Classification System Based On Chromosomal Abnormalities
by Jessica Langholtz and Maike Haehle
European researchers recently developed a new prognostic scoring system based on chromosomal abnormalities for myelodysplastic syndromes and acute myeloid leukemia patients.
Compared with the current prognostic system, the new system changed the risk group for 13 percent of patients (6 percent to more favorable and 7 percent to less favorable groups).
For the rest, see the article at MDS Beacon.